Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sulfasalazine plus aspirin for prevention of preeclampsia in high-risk pregnancy
IRCT20250708066406N1Phase 2Completed
- Sponsor
- Yasouj University of Medical Sciences
- Start
- Aug 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-blind trial of 5-aminosalicylic acid + sulphasalazine and aspirin in preeclampsia (2 arms), sponsored by Yasouj University of Medical Sciences. Primary endpoints: Preeclampsia, Gestational hypertension and 8 more. Started Aug 2025; status: completed.
02
Drugs
5-aminosalicylic acid + sulphasalazineaspirin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on IRCT20250708066406N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250708066406N1.